Latest Related Party Transactions News

Page 2 of 11
Booster Investment Scheme 2's Private Land and Property Fund swung back to profit with NZD 1.3 million after tax for the year ended March 2026, despite net asset value slipping due to unit redemptions. The Fund’s investment portfolio remains concentrated in unlisted New Zealand agricultural and property assets, while its Manager faces unrelated FMA proceedings.
Claire Turing
Claire Turing
29 June 2026
Group 6 Metals disclosed breaches of ASX Listing Rule 10.1 due to related party transactions made without required shareholder approval during a period of negative equity. The company will seek retrospective approval at a July meeting and has since returned to positive equity.
Maxwell Dee
Maxwell Dee
2 June 2026
Sarama Resources has secured A$1.42 million through the first tranche of its A$1.5 million equity placement, with the second tranche involving director participation pending shareholder approval.
Maxwell Dee
Maxwell Dee
29 May 2026
Vmoto Limited disclosed it held only one formal board meeting in FY25, relying heavily on circular resolutions, and outlined plans to increase meeting frequency in 2026. The company clarified its trade insurance arrangements and affirmed director independence amid ASX queries.
Victor Sage
Victor Sage
22 May 2026
Aland Equity Group (ASX: AEG) reveals advanced talks on a property funds management transaction linked to its chairman, explaining recent unusual share price activity.
Claire Turing
Claire Turing
7 May 2026
Careteq Limited has cleared $125,000 in director and company secretary loans a month ahead of schedule, using proceeds from a recent $2.2 million capital raising. This move strengthens the healthtech firm’s balance sheet and removes related-party debt ahead of maturity.
Ada Torres
Ada Torres
6 May 2026
Multistack International reversed a $1.68 million loss to report a $2.26 million profit in 2025, driven by $4 million in settlement and asset disposal income. The company plans to exit its loss-making Australian operations through a share disposal while exploring new business avenues.
Victor Sage
Victor Sage
1 May 2026
Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.
Ada Torres
Ada Torres
27 Apr 2026
N1 Holdings delivered record settlement volumes and a 127% surge in quarterly cash receipts despite challenging market conditions, driven by disciplined funding and operational efficiency.
Claire Turing
Claire Turing
23 Apr 2026
Accordant Group Limited’s shareholders have approved a significant share issuance under a Rights Offer, allowing the Hull Family Trust to increase its voting control beyond 20%. The move also greenlights additional share allocations to related parties to cover subscription shortfalls.
Claire Turing
Claire Turing
16 Apr 2026
Burgundy Diamond Mines has responded to ASX scrutiny over its related-party financing with Choron Holdings, asserting the arrangements were short-term, non-material cash-flow facilities properly disclosed in its half-year accounts.
Maxwell Dee
Maxwell Dee
16 Apr 2026
Genetic Technologies Limited remains under voluntary administration with minimal cash outflows and $0.276 million in cash as it navigates its Deed of Company Arrangement.
Ada Torres
Ada Torres
30 Mar 2026

Browse the archive

Full archive